BREADTH OF DONOR OPTIONS FOR PEOPLE WITH INHERITED DISEASES REQUIRING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT IN THE ERA OF ALTERNATIVE DONOR TRANSPLANTS USING POST-TRANSPLANTATION CYCLOPHOSPHAMIDE: